SEC Form 4 · accession 0001077183-18-000026
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Shovlin
Officer — President, Clinical Services
Period of report
May 25, 2018
Accepted (ET)
May 29, 2018 · 6:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 25, 2018 | M | 16,666 | $0.00 | A | 23,216 | D | |
| Common StockF1 | May 25, 2018 | F | 3,725 | $11.57 | D | 19,491 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted StockF2,F3,F4 | $0.00 | May 25, 2018 | M | 16,666 | D | May 25, 2018 | — | Common Stock | 16,666 | 33,334 | D |
| Stock Option (Right to Buy)F5 | $7.52 | holding | — | — | — | Apr 28, 2018 | Apr 28, 2022 | Common Stock | 200,000 | 200,000 | D |
| Stock Option (Right to Buy)F6 | $8.03 | holding | — | — | — | Feb 26, 2019 | Feb 26, 2023 | Common Stock | 288,500 | 288,500 | D |
| Stock Option (Right to Buy)F7 | $4.79 | holding | — | — | — | Oct 13, 2015 | Oct 13, 2019 | Common Stock | 300,000 | 300,000 | D |
| Stock Option (Right to Buy)F8 | $7.15 | holding | — | — | — | Apr 20, 2017 | Apr 20, 2021 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Shares withheld by NeoGenomics Laboratories, Inc. to satisfy the tax obligations in connection with the May 25, 2018 vesting of restricted stock.
- F2Each share of restricted stock represents the contingent right to receive one share of common stock upon vesting of the unit.
- F3Restricted stock will vest as follows; 16,666 vested on May 25, 2018 and 16,667 will vest on May 25, 2019 and 2020.
- F4These restricted stock will terminate upon the earliest of death, termination of employment or the last vesting date.
- F5On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- F6On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- F7On October 13, 2014, Mr. Shovlin was granted an option to purchase 300,000 shares. The options have time based vesting. On the first anniversary of the option grant date 75,000 shares vest. Then beginning on the thirteenth (13th) month through the fourth anniversary of the option grant date 6,250 shares will vest on a monthly basis.
- F8On April 20, 2016, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.